feed,title,long_url,short_url
Benzinga,FDA Approves Novartis' Scemblix In Two Chronic Myeloid Leukemia Settings,https://benzinga.com/general/biotech/21/11/23783625/fda-approves-novartis-scemblix-in-two-chronic-myeloid-leukemia-settings,https://j.mp/3CyZZtP
Benzinga,AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio,https://benzinga.com/general/biotech/21/11/23785332/astrazenecas-medimmune-terminates-dna-cancer-vaccine-program-with-inovio,https://j.mp/3jX5TxU
